Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Glomerulonephritis
Under what circumstances would you consider steroids in Staphylococcus-associated glomerulonephritis with crescents on kidney biopsy?
Related Questions
Do you prefer starting a SGLT2i before steroids in patients with IgA nephropathy and proteinuria > 1.0 gram/day who are unable to tolerate ACEi/ARB due to hypotension?
What steroid regimen do you typically use for induction therapy in patients with lupus nephritis?
How would you approach the treatment of crescentic fibrillary glomerulonephritis?
How do you approach the management of patients with suspected membranous lupus nephritis who are found to have positive PLA2R antibodies?
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
How would you approach a patient with class III and V lupus nephritis, already on HCQ, MMF, voclosporin and losartan, but has continued proteinuria not yet attaining complete renal response?
What do you feel are the potential barriers to widespread use of obinutuzumab in proliferative lupus nephritis?
Which clinical characteristics would prompt you to consider an oral factor B inhibitor such as iptacopan in the treatment of IgA nephropathy?
Under what circumstances would you consider obinutuzumab instead of rituximab when treating primary membranous nephropathy?
What factors do you consider when advising a patient with lupus nephritis on the safety of becoming pregnant?
